The use of snake venom protein-inspired candidate PseudoXa in patients taking anticoagulants, could combat severe bleeding in emergency surgery, says VarmX.
Researchers have found that a simple and inexpensive test can help
determine which patients with venous thromboembolism (VTE) are at
low risk for recurrence and can therefore avoid unnecessary and
potentially dangerous long-term anticoagulant...
AstraZeneca's anticoagulant Exanta (ximelagatran) has been launched
in Germany, its first market worldwide, for the prevention of blood
clots in patients undergoing hip or knee replacement surgery.
AstraZeneca has been granted approval for a new drug - the first in
its class - for the prevention of blood clotting complications
(venous thromboembolism) in major orthopaedic (hip or knee
replacement) surgery. It is the first new...